Profound Medical Corp. is a commercial-stage medical device enterprise focused on the development and marketing of customizable, incisionless therapeutic systems that utilize real-time magnetic resonance imaging thermal guidance. Its core medical technologies—including the TULSA-PRO and Sonalleve platforms—enable physicians to perform precise thermal ablation procedures for the non-invasive treatment of prostate cancer, benign prostatic hyperplasia, and uterine fibroids.